
Quantum Biopharma Ltd. — Investor Relations & Filings
Quantum Biopharma Ltd. is a biopharmaceutical company developing a portfolio of assets for neurodegenerative, neuropsychiatric, and inflammatory disorders. The company's lead pharmaceutical candidate is Lucid-MS, a patented, first-in-class neuroprotective compound for Multiple Sclerosis that targets myelin repair and has completed Phase 1 human clinical trials. Alongside its drug development pipeline, Quantum Biopharma is launching unbuzzd™, a functional beverage designed to support mental alertness and detoxification following alcohol consumption. The company's dual strategy focuses on both advanced pharmaceutical research and development and consumer wellness products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 6-K | 2026-05-18 | English | |
| 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-05-07 | English | |
| 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-04-22 | English | |
| 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-04-02 | English | |
| 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-04-01 | English | |
| 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-03-30 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 46383280 | FORM 6-K | 2026-05-18 | English | ||
| 42821432 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-05-07 | English | ||
| 35263952 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-04-22 | English | ||
| 33155540 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-04-02 | English | ||
| 33134570 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-04-01 | English | ||
| 33087644 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-03-30 | English | ||
| 33059377 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-03-27 | English | ||
| 33052122 | 20-F - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-03-26 | English | ||
| 33048166 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-03-26 | English | ||
| 33013173 | 6-K - Quantum Biopharma Ltd. (0001771885) (Filer) | 2026-03-23 | English | ||
| 31656292 | SCHEDULE 13G/A Filing | 2026-02-03 | English | ||
|
2025
4 filings
| |||||
| 13171354 | FORM 6-K | 2025-12-23 | English | ||
| 13171355 | 6-K | 2025-12-22 | English | ||
| 13171356 | 424B5 | 2025-12-22 | English | ||
| 13171357 | FORM 6-K | 2025-12-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ANTEROGEN CO., LTD.
Develops and commercializes cell therapies and orphan drugs…
|
065660 | KR | Manufacturing |
|
Antibiotice S.A.
Pharmaceutical firm manufacturing generic medicines, anti-i…
|
ATB | RO | Manufacturing |
|
Anuh Pharma Ltd.
Manufacturer of APIs and bulk drugs specializing in Macroli…
|
ANUHPHR | IN | Manufacturing |
|
Apellis Pharmaceuticals, Inc.
Biopharmaceutical company developing therapies by targeting…
|
APLS | US | Manufacturing |
|
Apeloa Pharmaceutical Co.,Ltd.
Integrated provider of APIs, CDMO services, and finished dr…
|
000739 | CN | Manufacturing |
|
APEX HEALTHCARE BERHAD
Integrated pharmaceutical group manufacturing and distribut…
|
— | MY | Manufacturing |
|
ApicHope Pharmaceutical Group Co.,Ltd
Pharmaceutical firm focused on pediatric, chronic, and card…
|
300723 | CN | Manufacturing |
|
Apimeds Pharmaceuticals US, Inc.
Clinical-stage biopharma developing a bee venom drug and AI…
|
APUS | US | Manufacturing |
|
Apogee Therapeutics, Inc.
Clinical-stage biotech developing biologics for immunologic…
|
APGE | US | Manufacturing |
|
Apollomics Inc.
Clinical-stage biotech developing innovative oncology and c…
|
APLM | US | Manufacturing |
Quantum Biopharma Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34475/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34475 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34475 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34475 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34475}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Quantum Biopharma Ltd. (id: 34475)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.